These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 589601

  • 1. Combinations of tetrahydrouridine and cytosine arabinoside in mouse tumors.
    Kreis W, Hession C, Soricelli A, Scully K.
    Cancer Treat Rep; 1977 Oct; 61(7):1355-64. PubMed ID: 589601
    [Abstract] [Full Text] [Related]

  • 2. Tetrahydrouridine: Physiologic disposition and effect upon deamination of cytosine arabinoside in man.
    Kreis W, Woodcock TM, Gordon CS, Krakoff IH.
    Cancer Treat Rep; 1977 Oct; 61(7):1347-53. PubMed ID: 589600
    [Abstract] [Full Text] [Related]

  • 3. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
    Avramis VI, Powell W.
    Cancer Invest; 1987 Oct; 5(4):293-9. PubMed ID: 3664332
    [Abstract] [Full Text] [Related]

  • 4. Influence of tetrahydrouridine on the phosphorylation of 1-beta-D-arabinofuranosyl-cytosine (ara-C) by enzymes from solid tumors in vitro.
    Furner RL, Mellett LB, Herren TC.
    J Pharmacol Exp Ther; 1975 Jul; 194(1):103-10. PubMed ID: 1057009
    [Abstract] [Full Text] [Related]

  • 5. Influence of tetrahydrouridine on the pharmacokinetics of intrathecally administered 1-beta-D-arabinofuranosylcytosine.
    Riccardi R, Chabner B, Glaubiger DL, Wood J, Poplack DG.
    Cancer Res; 1982 May; 42(5):1736-9. PubMed ID: 6896013
    [Abstract] [Full Text] [Related]

  • 6. Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside.
    Wong PP, Currie VE, Mackey RW, Krakoff IH, Tan CT, Burchenal JH, Young CW.
    Cancer Treat Rep; 1979 Aug; 63(8):1245-9. PubMed ID: 383291
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of 5-trifluoromethyldeoxycytidine and tetrahydrouridine to circumvent catabolism and exploit high levels of cytidine deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA, Boothman DA, Greer SB.
    Cancer Res; 1985 Nov; 45(11 Pt 1):5270-80. PubMed ID: 2932216
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic considerations in evaluating the effects of tetrahydrouridine on 5-azacytidine chemotherapy in L1210 leukemic mice.
    Kelly CJ, Gaudio L, Yesair DW, Schoenemann PT, Wodinsky I.
    Cancer Treat Rep; 1978 Jul; 62(7):1025-32. PubMed ID: 80268
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR, Campbell J, Rustum YM.
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [Abstract] [Full Text] [Related]

  • 16. Effect of tetrahydrouridine on metabolism and transport of 1-beta-D-arabinofuranosylcytosine in human cells.
    Riva C, Barra Y, Carcassonne Y, Cano JP, Rustum Y.
    Chemotherapy; 1992 Jun; 38(5):358-66. PubMed ID: 1286578
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Hori K, Tsuruo T, Naganuma K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.